Company
United StatesPublic company, NASDAQ: SLDBSolid Biosciences, Inc. (NASDAQ: SLDB), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Solid Biosciences, Inc. in Cambridge, Massachusetts. 1 FDA inspection on record, last inspected December 10, 2019. Publicly traded as NASDAQ: SLDB.
Company Profile
This profile covers Solid Biosciences, Inc. based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 10, 2019.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 10, 2019 | NAI | Biologics · Bioresearch Monitoring | 1114050 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Solid Biosciences, Inc.
Stock ticker
SLDB
Exchange
NASDAQ
Share price
$6.15
Market cap
$686.4M
Price as of
November 6, 2026
FEI Number
3015188407
Address
141 Portland St Fl 5, Cambridge, Massachusetts 02139, United States
Country
United States
ID: b3a876d5-1f29-4e8c-adc0-89ae0f42d55b